Paper42467271
Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients.
Chen Z and 1 other. Amino Acids, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients. Papers, record 42467271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42467271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Biomarkers, Tumor | Major topic |
| Succinic Acid | Major topic |
| Humans | |
| Female | |
| Prognosis | |
| Tumor Microenvironment | |
| Gene Expression Profiling | |
| Transcriptome |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34765287 | Role of succinylation modification in thyroid cancer and breast cancer. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/34765287 | PubMed |
| 2 | 40445120 | Cancer treatment and survivorship statistics, 2025. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/40445120 | PubMed |
| 3 | 30258934 | InfiniumPurify: An R package for estimating and accounting for tumor purity in cancer methylation research. | Genes Dis | 2018 | https://conductscience.org/library/papers/30258934 | PubMed |
| 4 | 35267540 | Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267540 | PubMed |
| 5 | 40024474 | ST3GAL1 regulates cancer cell migration through crosstalk between EGFR and neuropilin-1 signaling. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40024474 | PubMed |
| 6 | 33681201 | Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33681201 | PubMed |
| 7 | 37852104 | Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37852104 | PubMed |
| 8 | 32784928 | Understanding the Role of Innate Immune Cells and Identifying Genes in Breast Cancer Microenvironment. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32784928 | PubMed |
| 9 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 10 | 37817172 | Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model. | BMC Pulm Med | 2023 | https://conductscience.org/library/papers/37817172 | PubMed |
| 11 | 34409029 | Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34409029 | PubMed |
| 12 | 39851465 | Serum α1-AT Levels and SERPINA1 Molecular Analysis in Breast Cancer: An Experimental and Computational Study. | Diseases | 2024 | https://conductscience.org/library/papers/39851465 | PubMed |
| 13 | 40157085 | SLC35A2-mediated bisected GlcNAc-modified extracellular vesicles enhance immune regulation in breast cancer lung metastasis. | Int Immunopharmacol | 2025 | https://conductscience.org/library/papers/40157085 | PubMed |
| 14 | 30903449 | Succinylation Links Metabolism to Protein Functions. | Neurochem Res | 2019 | https://conductscience.org/library/papers/30903449 | PubMed |
| 15 | 37841939 | Association of MMP1 gene polymorphisms with breast cancer risk: A narrative review. | Health Sci Rep | 2023 | https://conductscience.org/library/papers/37841939 | PubMed |
| 16 | 31262773 | Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/31262773 | PubMed |
| 17 | 37056924 | SIRT7 Downregulation Promotes Breast Cancer Metastasis Via LAP2α-Induced Chromosomal Instability. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37056924 | PubMed |
| 18 | 30341162 | Maftools: efficient and comprehensive analysis of somatic variants in cancer. | Genome Res | 2018 | https://conductscience.org/library/papers/30341162 | PubMed |
| 19 | 32361569 | Breast cancer: Biology, biomarkers, and treatments. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/32361569 | PubMed |
| 20 | 38379549 | Protein succinylation: regulating metabolism and beyond. | Front Nutr | 2024 | https://conductscience.org/library/papers/38379549 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42467271
GET https://conductscience.org/api/papers/v1/42467271/references?page=2